NASDAQ: QLGNQualigen Therapeutics Inc Stock Ownership - Who owns Qualigen Therapeutics?
Insider buying vs selling
Have Qualigen Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when QLGN insiders and whales buy or sell their stock.
QLGN Shareholders
What type of owners hold Qualigen Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Noah Doyle | 459.30% | 7,787,131 | $23.75M | Insider |
| Javelin Venture Partners LP | 415.69% | 7,047,804 | $21.50M | Insider |
| Sekisui Diagnostics LLC | 116.80% | 1,980,233 | $6.04M | Insider |
| Stonehenge Partners LLC | 48.20% | 817,272 | $2.49M | Insider |
| Javelin Venture Partners I Spv I LLC | 19.04% | 322,753 | $984.40k | Insider |
| Michael S. Poirier | 12.40% | 210,207 | $641.13k | Insider |
| Matthew W. Foehr | 8.18% | 138,635 | $422.84k | Insider |
| Ira E. Ritter | 4.86% | 82,352 | $251.17k | Insider |
| Andrew J. Ritter | 4.86% | 82,352 | $251.17k | Insider |
| Michael D. Step | 4.54% | 77,000 | $234.85k | Insider |
QLGN vs Biotech Stocks
Qualigen Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.